The Atlanta Braves announced on Tuesday that outfielder and designated hitter Jurickson Profar has been suspended for 162 games after failing a performance-enhancing drug (PED) test for the second consecutive season. This suspension disqualifies Profar from participating in the upcoming 2026 MLB season and renders him ineligible for Team Netherlands in the World Baseball Classic.
The league confirmed that Profar tested positive for exogenous testosterone and its metabolites, with his suspension effective from March 6.
Braves Express Disappointment Over Profar’s Violation
The Braves issued a statement expressing their disappointment with the news. They highlighted that players receive continuous education about the MLB Drug Prevention and Treatment Program and its consequences.
“We were incredibly disappointed to learn that Jurickson tested positive for a performance-enhancing substance and is in violation of MLB’s Drug Prevention and Treatment Program,”
the Braves said late Tuesday.
“Our players are consistently educated about the program and the consequences if they are found to be in violation. The Atlanta Braves fully support the program.”
?Atlanta Braves, Team Statement
Implications of the Suspension for Profar and the Braves
Last year, Profar served an 80-game suspension for a similar infraction. Since the first offense results in an 80-game ban, the second offense triggers a 162-game suspension, and a third offense would mean a lifetime ban from the league. Profar’s ban means he will miss the entire 2026 season, making him ineligible for any postseason games, even if the Braves make the playoffs.
Profar, 33, enjoyed a career-best 2024 season with the San Diego Padres, batting .280 with a .380 on-base percentage and a .459 slugging percentage, accumulating 3.6 WAR and earning his first All-Star selection. His performance led to a three-year contract worth $42 million with the Braves. However, he will receive no salary during his current suspension after missing nearly half of last season.
During his 80 games last year, Profar posted a .245 batting average with 14 home runs and 56 runs scored, positioning himself as a key figure in Atlanta’s projected 2026 lineup. He was expected to bat cleanup and serve as the team’s designated hitter.
Atlanta Braves Face Roster Challenges Moving Forward
Profar’s absence creates a significant hole in the Braves’ lineup. Until catcher Sean Murphy and infielder Ha-Seong Kim recover from surgery, the team’s best option at designated hitter appears to be Eli White. Other possible candidates include non-roster invite Dom Smith and a limited free-agent pool featuring Rowdy Tellez, Justin Turner, Wilmer Flores, Tommy Pham, and Jesse Winker. Andrew McCutchen is another available veteran, should he opt to join after leaving Pittsburgh.
The Braves might also consider waiting for spring training cuts or exploring trade options. Some fans hope for Byron Buxton’s return to Georgia, although Buxton has expressed loyalty to the Minnesota Twins.
Season Outlook and Fan Expectations Despite Setback
Heading into March, the Braves were widely favored to win the NL East. Projections from FanGraphs and Baseball Prospectus’ PECOTA placed them slightly ahead of the Philadelphia Phillies and New York Mets. On betting platforms like DraftKings, Atlanta was listed with favorable odds despite stiff competition.
Profar’s suspension complicates this outlook and forces the Braves to adjust quickly as they aim to remain competitive in a challenging division.
